SHENZHEN, China, April 13, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, proudly marks a decade ...

MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today is proud to announce that its DNBSEQ-T20×2 ("T20") gene sequencing platform has been ...

SAN JOSE, Calif. and MARCO ISLAND, Fla., Feb. 24, 2026 /PRNewswire/ -- Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing ...

SHENZHEN, China, Sept. 9, 2019 /PRNewswire/ -- Today the ultra-high-throughput genetic sequencer DNBSEQ-T7, independently developed by MGI Tech Co., Ltd. (MGI), was officially delivered to business ...

DNBSEQ-T7 has the potential to output 7 TB of high-quality data daily that has been extensively applicable to Deep Exome Sequencing, Whole Genome Sequencing, Transcriptome Sequencing, Epigenome ...

COVID-19 has highlighted the importance of genomics in a pandemic response. In Africa, where genomics research is steadily catching up with that of European and North American countries, MGI (Shenzhen ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a global leader in ...

The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The ...

SAN CARLOS, Calif. and SHENZHEN, China, March 11, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the ...